<p>尽管宏观问题是一个因素，但导致顶级公司股票成为蓝筹股待售的更重要原因是公司特定问题。</p>
<p>一些公司特定问题可能超出管理层的控制。然而，许多此类问题源于公司高管的糟糕决策。例如，管理团队可能过分关注最终未能实现的新项目或业务线。即使这些项目最终实现，对公司的底线影响微乎其微。</p>
<p>有时，管理团队优先考虑财务工程而非提供最佳产品和服务可能导致不利局面。在这些情况下，公司声誉受损导致财务表现恶化。这反过来影响了市场对股票的看法。</p>
<p>这些以及其他管理失误，都影响以下七只蓝筹股的表现。随着它们因底层决策而从巅峰跌落，最好远离。</p>
<h2>苹果（AAPL）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>来源：sylv1rob1 / Shutterstock.com</p>
<p><strong>苹果</strong>（NASDAQ：<strong>AAPL</strong>）股价最近有所反弹，这得益于 Mag 7 部件最新更新有关利用生成式人工智能增长趋势的计划。然而，今年早些时候影响 AAPL 股价表现的关键问题仍未消失。</p>
<p>正如瑞银（UBS）的大卫·福特最近在一份关于 AAPL 股票的研究报告中所指出的，该公司在中国的 iPhone 需求疲软问题尚未解决。是的，在中国，需求疲软可能归咎于管理层有些牵强。</p>
<p>毕竟，苹果在中国失去市场份额并不仅仅是因为当地竞争的影响。不断升级的地缘政治紧张局势无疑也是一个因素。也就是说，除非苹果要么增加中国的需求，要么找到其他能抵消这一阻力的方法，最好还是避开 AAPL。</p>
<h2>波音（BA）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>来源：vaalaa / Shutterstock</p>
<p>在由于管理失误而成为蓝筹股待售的股票中，<strong>波音</strong>（NYSE：<strong>BA</strong>）绝对属于其中。这家航空巨头的股票经历了重大动荡。正如你可能知道的那样，这是由于人们对该公司商用飞机安全性的担忧重新加剧。</p>
<p>波音的管理团队可能有一项计划来缓解这些担忧，但直到公司重建声誉的道路可能还很漫长。目前，公众和市场将继续以最负面的态度看待波音。</p>
<p>也就是说，作为一家将股票回购和其他类型的财务工程置于研发和航空工程之上的公司。这种策略在短期内可能会取得成功，但波音似乎正在为长远付出代价。尽管这些问题已经导致 BA 股价自一月以来下跌三分之一，但还是要远离。尘埃尚未落定。</p>
<h2>高乐氏（CLX）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>来源：TY Lim / Shutterstock.com</p>
<p><strong>高乐氏</strong>（NYSE：<strong>CLX</strong>）是一家蓝筹股和股息贵族，连续 46 年增加股息。四年后，如果这家家庭产品制造商继续增加年度股息支付，该股将成为股息王。</p>
<p>然而，尽管 CLX 股票通过其 3.72% 的股息提供稳定收益，但近年来，这一收益被股价表现不佳所抵消。诚然，该公司的股价急剧下跌的很大一部分是由于疫情后的后遗症。其清洁产品的销售在 COVID 期间激增，但自那时起销售额和盈利能力有所下降。</p>
<p>然而，有一个糟糕的管理决定可以说已经导致股票的总回报乏善可陈。那就是不足的运营安全流程，使其容易受到去年八月的网络攻击。这次网络攻击的损失仍在影响高乐氏的财务表现。出售或避开 CLX。</p>
<h2>福特（F）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>来源：D K Grove / Shutterstock</p>
<p>与底特律三巨头相比，<strong>福特</strong>（NYSE：<strong>F</strong>）在转向生产更多电动汽车（EVs）方面更为积极。市场可能在几年前电动汽车热潮的高峰期赞扬这种转变。然而，现在明显看来，福特在电动汽车领域进展过快过大。</p>
<p>事后看来，这家汽车制造商应该追求一种不同的电动汽车战略。也许更类似于竞争对手 <strong>斯泰利斯</strong>（NYSE：<strong>STLA</strong>）的战略。福特的电动汽车转型使其在市场份额方面仅次于 <strong>特斯拉</strong>（NASDAQ：<strong>TSLA</strong>），但福特的电动汽车部门目前也在亏损数十亿。</p>
<p>以利润为重心的斯泰利斯，市场份额较低，但其电动汽车部门是盈利的。虽然福特正在削减其电动汽车努力，直到这一部门的现金流耗尽不再影响整体盈利能力，但考虑 F 股票为一只蓝筹股待售。</p>
<h2>IBM（IBM）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>来源：shutterstock.com/LCV</p>
<p>今年早些时候，市场对 <strong>IBM</strong>（NYSE：<strong>IBM</strong>）的人工智能战略几乎没有什么怨言。事实上，投资者将股价推高到近十年前的水平，因为这家拥有百年历史的科技公司将从通用人工智能革命中获益。</p>
<p>然而，最近，市场参与者对 IBM 股票有所犹豫。是的，其中一些可以归因于人工智能狂热自春季以来已经减退。然而，投资者对最新业绩和指引的更新也感到失望。</p>
<p>这还不是全部。正如 Seeking Alpha 的撰稿人 Stone Fox Capital 最近所指出的，IBM 削减资本支出的事实引发了关于该公司是否真正准备好利用人工智能增长趋势的疑问。在管理行动和业绩表明出真正的人工智能增长动力之前，最好避开 IBM。</p>
<h2>耐克（Nike）(NKE)</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>来源：Shutterstock</p>
<p>你可能认为 <strong>耐克</strong>（NYSE:<strong>NKE</strong>）是应该出售的蓝筹股之一，因为这家服装和鞋类行业领导者面临宏观风险。然而，高通胀和全球经济放缓的影响并不是导致耐克最近低迷的唯一因素。</p>
<p>至少，这是 InvestorPlace 的 Marc Guberti 的观点。本月早些时候，在阐述 NKE 股票的空头案例时，Guberti 指出了另一个因素，这个因素完全在管理层的控制范围内：产品创新。在这些逆风消散之前，公司可能会继续实现令人失望的营收和盈利增长。</p>
<p>过去的失望已经将 NKE 股价拉回接近 52 周低点。然而，如果即将到来的巴黎奥运会不能成为管理层所吹捧的扭转局面的催化剂，股价可能会进一步下跌。在考虑耐克股票时，最好不要购买。</p>
<h2>辉瑞（Pfizer）(PFE)</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>来源：Manuel Esteban / Shutterstock.com</p>
<p>自 2023 年以来，<strong>辉瑞</strong>（NYSE:<strong>PFE</strong>）一直是一只价值陷阱股。换句话说，这是一只看似被低估的股票，由于基本面糟糕而不断走低。抄底投资者已经多次买入这只大型制药股，希望他们是在低点买入。</p>
<p>不幸的是，PFE 股票继续走低。随着辉瑞新药销售尚未超过下降的 COVID-19 疫苗和治疗销售的影响，该公司仍在努力。是的，辉瑞正在努力弥补过去管理失误。一个主要例子是医疗保健分析师 Andrew Baum 加入公司担任战略和创新负责人。</p>
<p>然而，由于辉瑞继续在为快速增长市场如抗肥胖开发药物产品方面挣扎，扭转局面可能仍需要多年时间。目前，PFE 的股价表现不佳可能会抵消股息率为 5.96% 的股票上涨的潜力。</p>
<p><em>在本文发布之日，Thomas Niel 没有持有（直接或间接）本文提到的任何证券头寸。本文中表达的观点属于作者本人，遵守 InvestorPlace.com 的发布准则。</em></p>
<p>自 2016 年以来，InvestorPlace.com 的撰稿人 Thomas Niel 一直为网络出版物撰写单支股票分析。</p>
<p>蓝筹股</p>

波音

高乐氏

爱普股份

苹果

福特汽车

3 倍做多航空航天与国防 ETF - Direxion

<p>一些顶尖公司正在做出糟糕的管理决策，导致这七只蓝筹股股价下跌。苹果在中国面临弱势 iPhone 需求，而波音由于安全问题而声誉受损。高乐氏的股价表现不佳，且容易受到网络攻击，因此被认为是卖出对象，而福特向电动车转型的激进举措事与愿违。这些管理失误正在影响这些股票的财务表现</p>

<p>While macro-related issues are a factor, it’s company-specific issues that play a more significant role in causing shares from top companies to become blue-chip stocks to sell.</p>
<div class="lb-trans"><p>尽管宏观问题是一个因素，但导致顶级公司股票成为蓝筹股待售的更重要原因是公司特定问题。</p>
</div><p>Some company-specific issues can be out of management’s control. However, many of these types of issues stem from poor decisions by a company’s C-suite. For instance, management teams can focus too much on new projects or business lines that ultimately fail to come to fruition. If they do come to fruition, they have little impact on the bottom line.</p>
<div class="lb-trans"><p>一些公司特定问题可能超出管理层的控制。然而，许多此类问题源于公司高管的糟糕决策。例如，管理团队可能过分关注最终未能实现的新项目或业务线。即使这些项目最终实现，对公司的底线影响微乎其微。</p>
</div><p>Other times, management teams prioritizing financial engineering over providing the best products and services can end up in a bad situation. In these situations, a damaged reputation for the company leads to deteriorating financial performance. In turn, this affects the stock’s reputation in the eyes of the market.</p>
<div class="lb-trans"><p>有时，管理团队优先考虑财务工程而非提供最佳产品和服务可能导致不利局面。在这些情况下，公司声誉受损导致财务表现恶化。这反过来影响了市场对股票的看法。</p>
</div><p>These, and other management blunders, are in play with the following seven blue-chip stocks to sell. As they fall from the top of the heap due to bottom-shelf decisions, stay away.</p>
<div class="lb-trans"><p>这些以及其他管理失误，都影响以下七只蓝筹股的表现。随着它们因底层决策而从巅峰跌落，最好远离。</p>
</div><h2>Apple (AAPL)</h2>
<div class="lb-trans"><h2>苹果（AAPL）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: sylv1rob1 / Shutterstock.com</p>
<div class="lb-trans"><p>来源：sylv1rob1 / Shutterstock.com</p>
</div><p><strong>Apple</strong> (NASDAQ:<strong>AAPL</strong>) shares have been bouncing back lately, following the Mag 7 component’s latest updates regarding its plans to capitalize on the generative AI growth trend. However, the key issue affecting AAPL’s price performance earlier this year hasn’t gone away.</p>
<div class="lb-trans"><p><strong>苹果</strong>（NASDAQ：<strong>AAPL</strong>）股价最近有所反弹，这得益于 Mag 7 部件最新更新有关利用生成式人工智能增长趋势的计划。然而，今年早些时候影响 AAPL 股价表现的关键问题仍未消失。</p>
</div><p>As <strong>UBS’s</strong> David Vogt recently argued, in a research note on AAPL stock, the company is “not out of the woods yet” when it comes to weak iPhone demand in China. Yes, it may be somewhat of a stretch to say that demand weakness, at least in China, is the fault of management.</p>
<div class="lb-trans"><p>正如瑞银（UBS）的大卫·福特最近在一份关于 AAPL 股票的研究报告中所指出的，该公司在中国的 iPhone 需求疲软问题尚未解决。是的，在中国，需求疲软可能归咎于管理层有些牵强。</p>
</div><p>After all, it’s not just a matter of Apple losing ground in China due to the impact of local competition. Rising geopolitical tensions are undoubtedly a factor as well. That said, until Apple either shores up Chinese demand or figures out something else that can outweigh this headwind, it may be best to avoid AAPL.</p>
<div class="lb-trans"><p>毕竟，苹果在中国失去市场份额并不仅仅是因为当地竞争的影响。不断升级的地缘政治紧张局势无疑也是一个因素。也就是说，除非苹果要么增加中国的需求，要么找到其他能抵消这一阻力的方法，最好还是避开 AAPL。</p>
</div><h2>Boeing (BA)</h2>
<div class="lb-trans"><h2>波音（BA）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: vaalaa / Shutterstock</p>
<div class="lb-trans"><p>来源：vaalaa / Shutterstock</p>
</div><p>When it comes to blue-chip stocks to sell due to management blunders, <strong>Boeing</strong> (NYSE:<strong>BA</strong>) definitely belongs on that list. Shares in the aerospace giant have experienced major turbulence. As you likely know, that is due to renewed concerns about the safety of the company’s commercial aircraft.</p>
<div class="lb-trans"><p>在由于管理失误而成为蓝筹股待售的股票中，<strong>波音</strong>（NYSE：<strong>BA</strong>）绝对属于其中。这家航空巨头的股票经历了重大动荡。正如你可能知道的那样，这是由于人们对该公司商用飞机安全性的担忧重新加剧。</p>
</div><p>Boeing’s management may have a game plan to assuage these concerns, but it’s arguably a long road ahead until the company rebuilds its reputation. For now, the public and the market will continue to perceive Boeing in the most negative light.</p>
<div class="lb-trans"><p>波音的管理团队可能有一项计划来缓解这些担忧，但直到公司重建声誉的道路可能还很漫长。目前，公众和市场将继续以最负面的态度看待波音。</p>
</div><p>That is, as a company that prioritized stock buybacks and other types of financial engineering over R&amp;D and aerospace engineering. That strategy may have paid off in the near term, but Boing is seemingly paying the price in the long run. While these issues have already knocked BA stock down by a third since January, stay away. The dust has yet to settle.</p>
<div class="lb-trans"><p>也就是说，作为一家将股票回购和其他类型的财务工程置于研发和航空工程之上的公司。这种策略在短期内可能会取得成功，但波音似乎正在为长远付出代价。尽管这些问题已经导致 BA 股价自一月以来下跌三分之一，但还是要远离。尘埃尚未落定。</p>
</div><h2>Clorox (CLX)</h2>
<div class="lb-trans"><h2>高乐氏（CLX）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: TY Lim / Shutterstock.com</p>
<div class="lb-trans"><p>来源：TY Lim / Shutterstock.com</p>
</div><p><strong>Clorox</strong> (NYSE:<strong>CLX</strong>) is a blue-chip stock and a Dividend Aristocrat, with 46 years of consecutive dividend growth. Four years from now, if the household products manufacturer continues to increase its annual dividend payouts, the stock will become a Dividend King.</p>
<div class="lb-trans"><p><strong>高乐氏</strong>（NYSE：<strong>CLX</strong>）是一家蓝筹股和股息贵族，连续 46 年增加股息。四年后，如果这家家庭产品制造商继续增加年度股息支付，该股将成为股息王。</p>
</div><p>Yet, while CLX stock provides steady gains from its 3.72% dividend, in recent years that has been outweighed by the stock’s poor price performance. Admittedly, much of the stock’s steep declines have been due to the company’s post-pandemic hangover. Sales of its cleaning products surged during COVID, but sales and profitability have declined since.</p>
<div class="lb-trans"><p>然而，尽管 CLX 股票通过其 3.72% 的股息提供稳定收益，但近年来，这一收益被股价表现不佳所抵消。诚然，该公司的股价急剧下跌的很大一部分是由于疫情后的后遗症。其清洁产品的销售在 COVID 期间激增，但自那时起销售额和盈利能力有所下降。</p>
</div><p>However, there is one bad management decision that arguably has contributed to lackluster total returns for shares. That would be inadequate operational security processes, which left it vulnerable to a cyberattack last August. The damage from this cyberattack is still affecting Clorox’s fiscal performance. Sell or avoid CLX.</p>
<div class="lb-trans"><p>然而，有一个糟糕的管理决定可以说已经导致股票的总回报乏善可陈。那就是不足的运营安全流程，使其容易受到去年八月的网络攻击。这次网络攻击的损失仍在影响高乐氏的财务表现。出售或避开 CLX。</p>
</div><h2>Ford (F)</h2>
<div class="lb-trans"><h2>福特（F）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: D K Grove / Shutterstock.com</p>
<div class="lb-trans"><p>来源：D K Grove / Shutterstock</p>
</div><p>Compared to its Detroit Three rivals, <strong>Ford</strong> (NYSE:<strong>F</strong>) has been far more aggressive in its pivot towards producing more electric vehicles (EVs). The market may have lauded this change in focus during the height of EV mania several years ago. However, it’s clear now that Ford went too big and too fast with vehicle electrification.</p>
<div class="lb-trans"><p>与底特律三巨头相比，<strong>福特</strong>（NYSE：<strong>F</strong>）在转向生产更多电动汽车（EVs）方面更为积极。市场可能在几年前电动汽车热潮的高峰期赞扬这种转变。然而，现在明显看来，福特在电动汽车领域进展过快过大。</p>
</div><p>In hindsight, the automaker should have pursued a different EV strategy. Perhaps one more akin to that of competitor <strong>Stellantis</strong> (NYSE:<strong>STLA</strong>). Ford’s EV transformation has resulted in it becoming behind only <strong>Tesla</strong> (NASDAQ:<strong>TSLA</strong>) in terms of market share, but Ford’s EV division is also currently losing billions.</p>
<div class="lb-trans"><p>事后看来，这家汽车制造商应该追求一种不同的电动汽车战略。也许更类似于竞争对手 <strong>斯泰利斯</strong>（NYSE：<strong>STLA</strong>）的战略。福特的电动汽车转型使其在市场份额方面仅次于 <strong>特斯拉</strong>（NASDAQ：<strong>TSLA</strong>），但福特的电动汽车部门目前也在亏损数十亿。</p>
</div><p>Margin-focused Stellantis, on the other hand, has a lower market share yet its EV division is profitable. While Ford is scaling back its EV efforts until cash burn from this segment ceases to affect overall profitability, consider F stock one of the blue-chip stocks to sell.</p>
<div class="lb-trans"><p>以利润为重心的斯泰利斯，市场份额较低，但其电动汽车部门是盈利的。虽然福特正在削减其电动汽车努力，直到这一部门的现金流耗尽不再影响整体盈利能力，但考虑 F 股票为一只蓝筹股待售。</p>
</div><h2>IBM (IBM)</h2>
<div class="lb-trans"><h2>IBM（IBM）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: shutterstock.com/LCV</p>
<div class="lb-trans"><p>来源：shutterstock.com/LCV</p>
</div><p>Earlier this year, the market had few complaints about <strong>IBM’s</strong> (NYSE:<strong>IBM</strong>) AI strategy. In fact, investors bid up shares to prices last hit nearly a decade ago, on the view that the more than century-old tech firm would benefit greatly from the gen AI revolution.</p>
<div class="lb-trans"><p>今年早些时候，市场对 <strong>IBM</strong>（NYSE：<strong>IBM</strong>）的人工智能战略几乎没有什么怨言。事实上，投资者将股价推高到近十年前的水平，因为这家拥有百年历史的科技公司将从通用人工智能革命中获益。</p>
</div><p>More recently, however, market participants have had second thoughts about IBM stock. Yes, some of this can be chalked up to the fact that AI mania has waned since the spring. However, investors were also disappointed with the latest results and updates to guidance.</p>
<div class="lb-trans"><p>然而，最近，市场参与者对 IBM 股票有所犹豫。是的，其中一些可以归因于人工智能狂热自春季以来已经减退。然而，投资者对最新业绩和指引的更新也感到失望。</p>
</div><p>That’s not all. As Seeking Alpha contributor Stone Fox Capital recently argued, the fact that IBM is cutting back on capital expenditures raises questions over whether the company is really poised to capitalize on the AI growth trend. Until management actions and results indicate a bona fide AI growth catalyst, consider it best to steer clear of Big Blue.</p>
<div class="lb-trans"><p>这还不是全部。正如 Seeking Alpha 的撰稿人 Stone Fox Capital 最近所指出的，IBM 削减资本支出的事实引发了关于该公司是否真正准备好利用人工智能增长趋势的疑问。在管理行动和业绩表明出真正的人工智能增长动力之前，最好避开 IBM。</p>
</div><h2>Nike (NKE)</h2>
<div class="lb-trans"><h2>耐克（Nike）(NKE)</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: Shutterstock</p>
<div class="lb-trans"><p>来源：Shutterstock</p>
</div><p>You may think <strong>Nike</strong> (NYSE:<strong>NKE</strong>) is one of the blue-chip stocks to sell due to macro headwinds for this leader in the apparel and footwear industry. However, the impact of high inflation and a global economic slowdown aren’t the only factors driving Nike’s recent slump.</p>
<div class="lb-trans"><p>你可能认为 <strong>耐克</strong>（NYSE:<strong>NKE</strong>）是应该出售的蓝筹股之一，因为这家服装和鞋类行业领导者面临宏观风险。然而，高通胀和全球经济放缓的影响并不是导致耐克最近低迷的唯一因素。</p>
</div><p>At least, that’s the view of InvestorPlace’s Marc Guberti. Earlier this month, when laying out the NKE stock bear case, Guberti pointed to another factor, one that’s well within management’s control: product innovation. Until these headwinds dissipate, the company will likely continue to deliver underwhelming revenue and earnings growth.</p>
<div class="lb-trans"><p>至少，这是 InvestorPlace 的 Marc Guberti 的观点。本月早些时候，在阐述 NKE 股票的空头案例时，Guberti 指出了另一个因素，这个因素完全在管理层的控制范围内：产品创新。在这些逆风消散之前，公司可能会继续实现令人失望的营收和盈利增长。</p>
</div><p>Past disappointment has already knocked NKE back down near its 52-week low. However, if the upcoming Paris Olympics fail to be the turnaround catalyst that management has hyped it up to be, further price declines could be in the cards. When it comes to Nike stock, just don’t buy it.</p>
<div class="lb-trans"><p>过去的失望已经将 NKE 股价拉回接近 52 周低点。然而，如果即将到来的巴黎奥运会不能成为管理层所吹捧的扭转局面的催化剂，股价可能会进一步下跌。在考虑耐克股票时，最好不要购买。</p>
</div><h2>Pfizer (PFE)</h2>
<div class="lb-trans"><h2>辉瑞（Pfizer）(PFE)</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: Manuel Esteban / Shutterstock.com</p>
<div class="lb-trans"><p>来源：Manuel Esteban / Shutterstock.com</p>
</div><p>Since 2023, <strong>Pfizer</strong> (NYSE:<strong>PFE</strong>) has been a value trap stock. In other words, a seemingly undervalued stock that due to poor fundamentals keeps on getting cheaper. Bottom-fishing investors have bought the dip many times with the big pharma stock, hoping they were buying in at the bottom.</p>
<div class="lb-trans"><p>自 2023 年以来，<strong>辉瑞</strong>（NYSE:<strong>PFE</strong>）一直是一只价值陷阱股。换句话说，这是一只看似被低估的股票，由于基本面糟糕而不断走低。抄底投资者已经多次买入这只大型制药股，希望他们是在低点买入。</p>
</div><p>Unfortunately, PFE stock has continued to trend lower. The impact of declining COVID-19 vaccine and treatment sales has yet to be outweighed by the sale of new drugs in Pfizer’s pipeline. Yes, Pfizer is trying to make up for past management missteps. A prime example is the onboarding of healthcare analyst Andrew Baum as the company’s new head of strategy and innovation.</p>
<div class="lb-trans"><p>不幸的是，PFE 股票继续走低。随着辉瑞新药销售尚未超过下降的 COVID-19 疫苗和治疗销售的影响，该公司仍在努力。是的，辉瑞正在努力弥补过去管理失误。一个主要例子是医疗保健分析师 Andrew Baum 加入公司担任战略和创新负责人。</p>
</div><p>However, as Pfizer continues to struggle to develop drug products for fast-growing markets like anti-obesity, a turnaround may still be many years in the making. For now, PFE’s poor price performance could keep countering the upside from the stock’s 5.96% dividend.</p>
<div class="lb-trans"><p>然而，由于辉瑞继续在为快速增长市场如抗肥胖开发药物产品方面挣扎，扭转局面可能仍需要多年时间。目前，PFE 的股价表现不佳可能会抵消股息率为 5.96% 的股票上涨的潜力。</p>
</div><p><em>On the date of publication, Thomas Niel did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com</em> <em>Publishing Guidelines</em>.</p>
<div class="lb-trans"><p><em>在本文发布之日，Thomas Niel 没有持有（直接或间接）本文提到的任何证券头寸。本文中表达的观点属于作者本人，遵守 InvestorPlace.com 的发布准则。</em></p>
</div><p>Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.</p>
<div class="lb-trans"><p>自 2016 年以来，InvestorPlace.com 的撰稿人 Thomas Niel 一直为网络出版物撰写单支股票分析。</p>
</div><p>Blue-Chip Stocks</p>
<div class="lb-trans"><p>蓝筹股</p>
</div>

蓝筹股失误：管理层失误不断增加的 7 只股票